These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18974620)

  • 1. [MucoRice: development of rice-based oral vaccine].
    Yuki Y; Kiyono H
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):369-74. PubMed ID: 18974620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination.
    Nochi T; Takagi H; Yuki Y; Yang L; Masumura T; Mejima M; Nakanishi U; Matsumura A; Uozumi A; Hiroi T; Morita S; Tanaka K; Takaiwa F; Kiyono H
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):10986-91. PubMed ID: 17573530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modification.
    Yuki Y; Mejima M; Kurokawa S; Hiroiwa T; Takahashi Y; Tokuhara D; Nochi T; Katakai Y; Kuroda M; Takeyama N; Kashima K; Abe M; Chen Y; Nakanishi U; Masumura T; Takeuchi Y; Kozuka-Hata H; Shibata H; Oyama M; Tanaka K; Kiyono H
    Plant Biotechnol J; 2013 Sep; 11(7):799-808. PubMed ID: 23601492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity.
    Yuki Y; Tokuhara D; Nochi T; Yasuda H; Mejima M; Kurokawa S; Takahashi Y; Kataoka N; Nakanishi U; Hagiwara Y; Fujihashi K; Takaiwa F; Kiyono H
    Vaccine; 2009 Oct; 27(43):5982-8. PubMed ID: 19665603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MucoRice-cholera toxin B-subunit, a rice-based oral cholera vaccine, down-regulates the expression of α-amylase/trypsin inhibitor-like protein family as major rice allergens.
    Kurokawa S; Nakamura R; Mejima M; Kozuka-Hata H; Kuroda M; Takeyama N; Oyama M; Satoh S; Kiyono H; Masumura T; Teshima R; Yuki Y
    J Proteome Res; 2013 Jul; 12(7):3372-82. PubMed ID: 23763241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral rice-based vaccine induces passive and active immunity against enterotoxigenic E. coli-mediated diarrhea in pigs.
    Takeyama N; Yuki Y; Tokuhara D; Oroku K; Mejima M; Kurokawa S; Kuroda M; Kodama T; Nagai S; Ueda S; Kiyono H
    Vaccine; 2015 Sep; 33(39):5204-11. PubMed ID: 26254309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
    Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H
    J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel transgenic rice-based vaccines.
    Azegami T; Itoh H; Kiyono H; Yuki Y
    Arch Immunol Ther Exp (Warsz); 2015 Apr; 63(2):87-99. PubMed ID: 25027548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good manufacturing practices production of a purification-free oral cholera vaccine expressed in transgenic rice plants.
    Kashima K; Yuki Y; Mejima M; Kurokawa S; Suzuki Y; Minakawa S; Takeyama N; Fukuyama Y; Azegami T; Tanimoto T; Kuroda M; Tamura M; Gomi Y; Kiyono H
    Plant Cell Rep; 2016 Mar; 35(3):667-79. PubMed ID: 26661780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H; Peng X; Jiao H; Zhao D; Ouyang J
    Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults.
    Yuki Y; Nojima M; Kashima K; Sugiura K; Maruyama S; Kurokawa S; Yamanoue T; Nakahashi-Ouchida R; Nakajima H; Hiraizumi T; Kohno H; Goto E; Fujihashi K; Kiyono H
    Vaccine; 2022 May; 40(24):3372-3379. PubMed ID: 35484039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNAi-mediated suppression of endogenous storage proteins leads to a change in localization of overexpressed cholera toxin B-subunit and the allergen protein RAG2 in rice seeds.
    Kurokawa S; Kuroda M; Mejima M; Nakamura R; Takahashi Y; Sagara H; Takeyama N; Satoh S; Kiyono H; Teshima R; Masumura T; Yuki Y
    Plant Cell Rep; 2014 Jan; 33(1):75-87. PubMed ID: 24085308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNAi suppression of rice endogenous storage proteins enhances the production of rice-based Botulinum neutrotoxin type A vaccine.
    Yuki Y; Mejima M; Kurokawa S; Hiroiwa T; Kong IG; Kuroda M; Takahashi Y; Nochi T; Tokuhara D; Kohda T; Kozaki S; Kiyono H
    Vaccine; 2012 Jun; 30(28):4160-6. PubMed ID: 22554467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative whole-genome and proteomics analyses of the next seed bank and the original master seed bank of MucoRice-CTB 51A line, a rice-based oral cholera vaccine.
    Sasou A; Yuki Y; Honma A; Sugiura K; Kashima K; Kozuka-Hata H; Nojima M; Oyama M; Kurokawa S; Maruyama S; Kuroda M; Tanoue S; Takamatsu N; Fujihashi K; Goto E; Kiyono H
    BMC Genomics; 2021 Jan; 22(1):59. PubMed ID: 33468052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal vaccines: novel advances in technology and delivery.
    Yuki Y; Kiyono H
    Expert Rev Vaccines; 2009 Aug; 8(8):1083-97. PubMed ID: 19627189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MucoRice-CTB line 19A, a new marker-free transgenic rice-based cholera vaccine produced in an LED-based hydroponic system.
    Yuki Y; Kurokawa S; Sugiura K; Kashima K; Maruyama S; Yamanoue T; Honma A; Mejima M; Takeyama N; Kuroda M; Kozuka-Hata H; Oyama M; Masumura T; Nakahashi-Ouchida R; Fujihashi K; Hiraizumi T; Goto E; Kiyono H
    Front Plant Sci; 2024; 15():1342662. PubMed ID: 38559768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative whole-genome analyses of selection marker-free rice-based cholera toxin B-subunit vaccine lines and wild-type lines.
    Kashima K; Mejima M; Kurokawa S; Kuroda M; Kiyono H; Yuki Y
    BMC Genomics; 2015 Feb; 16(1):48. PubMed ID: 25653106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (As16) of Ascaris suum fused with cholera toxin B subunit.
    Matsumoto Y; Suzuki S; Nozoye T; Yamakawa T; Takashima Y; Arakawa T; Tsuji N; Takaiwa F; Hayashi Y
    Transgenic Res; 2009 Apr; 18(2):185-92. PubMed ID: 18763047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seed Metabolome Analysis of a Transgenic Rice Line Expressing Cholera Toxin B-subunit.
    Ogawa T; Kashima K; Yuki Y; Mejima M; Kurokawa S; Kuroda M; Okazawa A; Kiyono H; Ohta D
    Sci Rep; 2017 Jul; 7(1):5196. PubMed ID: 28701756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.